Cryptococcal aortitis presenting as a ruptured mycotic abdominal aortic aneurysm.
Mycotic processes occasionally complicate atherosclerotic aortic disease and usually require aggressive surgical therapy to control sepsis and prevent arterial rupture. Rarely, fungal organisms are responsible for primary infection of the abdominal aorta. We report the first case of Cryptococcal aortitis presenting as a ruptured abdominal aortic aneurysm. The surgical, pathologic, and microbiologic aspects of fungal aortitis are discussed.
Deitch
J S
JS
Division of Surgical Sciences and the Department of Internal Medicine, Section on Infectious Diseases, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Plonk
G W
GW
Hagenstad
C
C
Hansen
K J
KJ
Peacock
J E
JE
Ligush
J
J
D000785:Aneurysm, Infected / Q000150:complications*; D017542:Aneurysm, Ruptured / Q000209:etiology*; D000935:Antifungal Agents / Q000627:therapeutic use; D017544:Aortic Aneurysm, Abdominal / Q000209:etiology*; D001025:Aortitis / Q000150:complications / Q000382:microbiology*; D003453:Cryptococcosis / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged
D000935:Antifungal Agents